Efficacy and Safety of Vonoprazan‐Based Dual Therapies With Different Antibiotics Versus Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Prospective, Four‐Arm, Randomized Controlled Trial

Documenti analoghi

• Efficacy and Safety of Vonoprazan‐Based Dual, Triple, and Quadruple Therapies for Helicobacter pylori Eradication: A Randomized Controlled Trial
  di: Jin‐Yan Zhang, et al.
  Pubblicazione: (2026)
• Vonoprazan Dual or Triple Therapy Versus Bismuth‐Quadruple Therapy as First‐Line Therapy for Helicobacter pylori Infection: A Three‐Arm, Randomized Clinical Trial
  di: Ka Shing Cheung, et al.
  Pubblicazione: (2024)
• Vonoprazan Improves Efficacy of Bismuth Quadruple Therapy for Helicobacter pylori Rescue Treatment: A Multicenter Randomized Controlled Trial
  di: Tian‐Lian Yan, et al.
  Pubblicazione: (2025)
• Efficacy of Three Amoxicillin Doses in Vonoprazan Dual Therapy for Helicobacter pylori Eradication: A Randomized Noninferiority Trial
  di: Ruolin Peng, et al.
  Pubblicazione: (2025)
• Antibiotic Combinations in Bismuth‐Containing Quadruple Therapy for Helicobacter pylori Eradication: A Systematic Review and Network Meta‐Analysis
  di: Miao Duan, et al.
  Pubblicazione: (2025)